|

Alzheimer's Disease Clinical Trials in Arizona

35 recruiting studies across 3 cities

Browse by City

Mesa
32 trials
Phoenix
32 trials
Tucson
6 trials

All Trials in Arizona

Phase
Trial Phase Dist.
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Phase 3<1 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Phase 3<1 mi
A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early ADPhase 3<1 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseasePhase 2<1 mi
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)Phase 2<1 mi
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisPhase 2<1 mi
Arizona Alzheimer's Disease Research Center (ADRC)—<1 mi
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)Phase 2<1 mi
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)—<1 mi
Repurposing Siponimod for Alzheimer's DiseasePhase 2<1 mi
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)Phase 1/2<1 mi
A Study of AMDX-2011P in Participants With Alzheimer's DiseasePhase 2<1 mi
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's DiseasePhase 2<1 mi
Time Restricted Eating in Alzheimer's DiseaseN/A<1 mi
[18F]PI-2620 Phase 3 Histopathological StudyPhase 3<1 mi
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 3<1 mi
PROMIS and Mobility Evaluation in Sarcoma Patients—<1 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)Phase 3<1 mi
Early-Stage Partner in Care Living Alone PlusN/A<1 mi
Trial-Ready Cohort-Down Syndrome (TRC-DS)—<1 mi
Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies—<1 mi
Goal Setting to Promote Physical Activity Adherence in Midlife AdultsN/A<1 mi
A SMART Trial of Adaptive Exercises to Optimize Aerobic-Fitness ResponsesN/A<1 mi
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesPhase 3<1 mi
Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's DiseasePhase 23 mi
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples With Implications for Alzheimer's Disease RiskPhase 23 mi
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults StudyN/A3 mi
Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's PatientsN/A3 mi
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)Phase 38 mi
ACP-204 in Adults With Alzheimer's Disease PsychosisPhase 2/38 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)Phase 38 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)Phase 38 mi
A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease—8 mi
Longitudinal Early-onset Alzheimer's Disease Study Protocol—15 mi
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 315 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.